Jung‐Chin Chang

468 citations
23 papers · 336 indexed · h-index 11
Topics
Drug Transport and Resistance Mechanisms (6 papers)Pediatric Hepatobiliary Diseases and Treatments (5 papers)Cancer, Hypoxia, and Metabolism (4 papers)
Partner nations
NetherlandsBelgiumBrazil

In The Last Decade

Jung‐Chin Chang

22 papers receiving 330 citations

Peers

Jung‐Chin Chang
Comparison fields: 5 of 73
  • Molecular Biology 130
  • Hepatology 115
  • Surgery 111
  • Epidemiology 75
  • Oncology 62
Replace Xuzhen Yan with:
Xuzhen Yan China
Hubert Y. Luu United States
Eiko Saijou Japan
Lorenzo Nevi Italy
Michihiko Takesue Japan
Ping‐Fang Hu China
Freya Vaeyens Belgium
Max A. Cayo United States
R A Faris United States
Adi Egozi Israel
Jung‐Chin Chang relative to Xuzhen Yan China Xuzhen Yan's profile →
Citations per field
00.5×11×
Xuzhen Yan · 1×
Citations per year

Countries citing papers authored by Jung‐Chin Chang

Since Specialization
Citations

This map shows the geographic impact of Jung‐Chin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Chin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Chin Chang more than expected).

Fields of papers citing papers by Jung‐Chin Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Chin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Chin Chang. The network helps show where Jung‐Chin Chang may publish in the future.

Co-authorship network of co-authors of Jung‐Chin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Chin Chang. A scholar is included among the top collaborators of Jung‐Chin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Chin Chang. Jung‐Chin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 3
4 13
5 5
6 5
7 10
8 16
9 18
10 25
11 6
12 28
13 28
14 8
15 17
16 55
17 9
18 35
19 42
20 6

About Jung‐Chin Chang

Jung‐Chin Chang is a scholar working on Hepatology, Cancer Research and Oncology, having authored 23 papers that have together received 336 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Hepatology (115 citations), Surgery (111 citations) and Oncology (62 citations). Jung‐Chin Chang has collaborated with scholars based in Netherlands, Belgium and Brazil. Frequent co-authors include Simei Go, Ronald P.J. Oude Elferink, Ronald Oude‐Elferink, Ulrich Beuers, Arthur J. Verhoeven, Coen C. Paulusma, Ronald Oude Elferink, Dirk R. de Waart, Patricia Muñoz-Garrido and Ruurdtje Hoekstra. Their work appears in journals such as Hepatology, International Journal of Molecular Sciences and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026